Volkmar Braun first discovered bacterial lipoproteins in 1973 through the identification of a fatty-acid modification of Lpp, or Braun's lipoprotein, in E. coli (Hantke and Braun, 1973). Through early biochemical and genetics studies and more recent structural analysis, the lipoprotein modification pathway is increasingly well understood. A general consensus exists regarding the well-studied tripartite stages of the lipoprotein modification pathway. Upon insertion into the cytoplasmic membrane, a diacylglyceryl group is added to the lipoprotein, the membrane-spanning signal peptide is cleaved and the protein stays membrane anchored by its diacylglyceryl moiety. Finally, N-acylation results in the formation of mature triacylated lipoprotein (Figure 1). In diderm bacteria, including proteobacteria and some high GC content Gram-positive bacteria, including Streptomyces, Corynebacteria, and Mycobacteria, lipoproteins are triacylated following this classical pathway, although in some instances Lnt and/or Lsp are not essential components for cell viability (discussed below). In monoderm bacteria it was long thought that only diacylated lipoproteins existed; however, recent studies illustrate that alternative lipid modifications occur in firmicutes and mollicutes, but not all enzymes catalyzing these reactions have been